Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
- PMID: 34847240
- PMCID: PMC8631711
- DOI: 10.1002/14651858.CD011823.pub3
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
Abstract
This review has been withdrawn because it has been found to be in breach of the Cochrane Commercial Sponsorship policy clause 2: 'Individuals who are currently employed or where employed any time in the last three years by a company that has a real or potential financial interest in the outcome of the review (including but not limited to drug companies or medical device manufacturers); or who hold or have applied for a patent related to the review are prohibited from being Cochrane Review authors. In most cases, current or previous employment would be characterized by the affiliation statement made by the author at the title registration, protocol, or review stage of the review'.
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Retraction of
-
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD011823. doi: 10.1002/14651858.CD011823.pub2. Cochrane Database Syst Rev. 2017. Retraction in: Cochrane Database Syst Rev. 2021 Nov 30;11:CD011823. doi: 10.1002/14651858.CD011823.pub3. PMID: 28884473 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
